Read the latest reports on EAN clinical fellowships in Paris (FR) and Erlangen (DE)
EAN Congress 2025 relocated to HELSINKI due to UN summit (dates remain 21-24 June)
September 20, 2024
Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.
EAN co-hosting G7 side-event in Ancona, Italy, on 8 October
September 13, 2024
Upcoming Joint Sessions at Partner Societies’ Congresses
August 26, 2024
Latest Posts
-
-
EAN NewsTop Articles
EAN & National Neurological Societies gather to support neurology advocacy
December 27, 2021The European Academy of Neurology launched the first of its new National Neurological Society Forum meetings on Wednesday, December 15. Representatives from more than 40 societies which are EAN institutional members joined the meeting to get a glimpse of EAN’s progress in advocating for neurology and brain health on the European level. -
EAN News
EAN-EBRAINS Joint Workshop: The Future of Medical Data Sharing in Clinical Neurosciences
December 23, 2021The HBP and EBRAINS together with the European Academy of Neurology invited the entire scientific community to join a workshop on the Future of Medical Data Sharing in Clinical Neurosciences on 9–11 December 2021. -
Did you miss any interesting EAN educational events last year? Check out all our webcasts from the virtual events!.
-
The editorial team of the European Journal of Neurology welcomes two new colleagues, starting in January 2022. Alessandro Tessitore and Barbara Borroni have both joined as Associate Editors.
-
Breaking news
Study of mirtazapine for agitated behaviors in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
December 9, 2021This parallel-group, double- blind, ransomised, placebo-controlled trial conducted in 26 United Kingdom centres, investigated the efficacy and tolerability of mirtazapine versus placebo in treating agitation in patients with probable or possible Alzheimer’s disease. -
Breaking news
The impact of smoking cessation on multiple sclerosis disease progression
December 9, 2021This study investigated the potential benefits of smoking cessation in slowing down clinical progression in patients with multiple sclerosis. -
Breaking newsCOVID-19
C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy
December 9, 2021Twenty patients hospitalized with COVID-19 encephalopathy were included in this retrospective cohort study. -
Breaking newsCOVID-19
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study
December 7, 2021In this case-control study, the authors evaluated NSSS from a cohort of 7,812,845 BNT162b2 first-dose recipients, of whom 10,929 reported an adverse event following immunization. -
This narrative review was conducted to collect and discuss published data about neurological side effects of SARS-CoV-2 vaccines in order to discover type, frequency, treatment, and outcome of these side effects.
-
Breaking newsCOVID-19
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
December 7, 2021The objective of this retrospective cross-sectional study was to generate real-world multiple sclerosis–specific vaccine safety information, particularly in the context of specific DMTs, and provide information to mitigate specific concerns in vaccine hesitant PwMS. -
Breaking newsCOVID-19
Multifocal and Microvascular Involvement in Ischemic Stroke During COVID-19: A Cohort Study With Comparison With Non-COVID-19 Stroke
December 7, 2021This single-center retrospective observational study compared stroke characteristics between patients with and without COVID-19. -
Breaking newsCOVID-19
Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
December 7, 2021In this article the author sought to highlight the most remarkable findings concerning headache secondary to COVID-19, specifically focusing on epidemiology, characteristics, pathophysiology, and treatments. -
Breaking newsCOVID-19
Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study
December 7, 2021In this study the authors retrospectively studied 4742 patients with acute infectious respiratory disease (AIRD); 2579 were diagnosed to have COVID-19 and treated with heparin, whereas 2163 had other causes of AIRD. -
Breaking newsCOVID-19
Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients
December 7, 2021In this article the authors used state-of-the-art multiplexed immunostaining of human brains and demonstrated that expression of the SARS-CoV-2 receptor ACE2 is restricted to a subset of neurovascular pericytes.